# Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer

> **NCT02484040** · PHASE3 · UNKNOWN · sponsor: **Jong Hoon Lee** · enrollment: 370 (estimated)

## Conditions studied

- Response to Toxin
- Toxicity
- Recurrence

## Interventions

- **RADIATION:** Two-week course of radiation
- **DRUG:** Two-week course of radiation

## Key facts

- **NCT ID:** NCT02484040
- **Lead sponsor:** Jong Hoon Lee
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2019-07
- **Final completion:** 2021-07
- **Target enrollment:** 370 (ESTIMATED)
- **Last updated:** 2017-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02484040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02484040, "Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02484040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*